{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:18Z","timestamp":1790621718002,"version":"4.1.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1704,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1365-2133.2010.10108.x","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T16:51:18Z","timestamp":1288371078000},"page":"no-no","source":"Crossref","is-referenced-by-count":28,"title":["Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma"],"prefix":"10.1093","author":[{"given":"N.","family":"Booken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"Klemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Goerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Utikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,1,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2006.04.025","article-title":"Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma","volume":"55","author":"Demierre","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB4|cit4","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/026921639901300314","article-title":"The use of amitriptyline in mycosis fungoides","volume":"13","author":"Coe","year":"1999","journal-title":"Palliat Med"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","article-title":"Neuropeptides and their receptors in psoriatic skin in relation to pruritus","volume":"156","author":"Chang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"e10968","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMc1003937","article-title":"Aprepitant for erlotinib-induced pruritus","volume":"363","author":"Vincenzi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMc0906670","article-title":"Aprepitant as an antipruritic agent?","volume":"361","author":"Duval","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/cncr.11433","article-title":"Aprepitant Protocol 054 Study Group. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America","volume":"97","author":"Poli-Bigelli","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","article-title":"Lack of efficacy of the substance P (neurokinin 1 receptor) antagonist aprepitant in the treatment of major depressive disorder","volume":"59","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10108.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00520-010-0895-9","article-title":"Aprepitant against pruritus in patients with solid tumours","volume":"18","author":"Vincenzi","year":"2010","journal-title":"Support Care Cancer"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10108.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10108.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:50:33Z","timestamp":1676382633000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/3\/665\/6643910"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10108.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}